Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predicting the risk of locoregional recurrence after early breast cancer: an external validation of the Dutch INFLUENCE-nomogram with clinical cancer registry data from Germany.
Voelkel V, Draeger T, Groothuis-Oudshoorn CGM, de Munck L, Hueting T, Gerken M, Klinkhammer-Schalke M, Lavric M, Siesling S. Voelkel V, et al. J Cancer Res Clin Oncol. 2019 Jul;145(7):1823-1833. doi: 10.1007/s00432-019-02904-4. Epub 2019 Mar 29. J Cancer Res Clin Oncol. 2019. PMID: 30927074 Free PMC article.
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging.
Soeterik TFW, Hueting TA, Israel B, van Melick HHE, Dijksman LM, Stomps S, Biesma DH, Koffijberg H, Sedelaar M, Witjes JA, van Basten JA. Soeterik TFW, et al. Among authors: hueting ta. BJU Int. 2021 Aug;128(2):236-243. doi: 10.1111/bju.15376. Epub 2021 May 16. BJU Int. 2021. PMID: 33630398
Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model.
Völkel V, Hueting TA, Draeger T, van Maaren MC, de Munck L, Strobbe LJA, Sonke GS, Schmidt MK, van Hezewijk M, Groothuis-Oudshoorn CGM, Siesling S. Völkel V, et al. Among authors: hueting ta. Breast Cancer Res Treat. 2021 Oct;189(3):817-826. doi: 10.1007/s10549-021-06335-z. Epub 2021 Aug 2. Breast Cancer Res Treat. 2021. PMID: 34338943 Free PMC article.
The use and misuse of risk prediction tools for clinical decision-making.
van Maaren MC, Hueting TA, Völkel V, van Hezewijk M, Strobbe LJ, Siesling S. van Maaren MC, et al. Among authors: hueting ta. Breast. 2023 Jun;69:428-430. doi: 10.1016/j.breast.2023.01.006. Epub 2023 Jan 21. Breast. 2023. PMID: 36709092 Free PMC article. No abstract available.